Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  View Cart Check Out

Country Report

NRT Smoking Cessation Aids in

NRT Smoking Cessation Aids in Australia

Oct 2019

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Consistently positive growth as increasing numbers of Australians quit smoking

Positive sales growth was seen again in NRT smoking cessation aids in 2018 as more stringent tobacco control regulations and rising tobacco taxes provided further incentives for tobacco users to quit smoking. September 2019 saw a further 12.

Young Australians taken up smoking far less than previous generations

The long-term growth prospects of NRT smoking cessation aids are under pressure as the consumer base for the category is narrowing. The main reason for this is that young Australians are less likely to take up smoking than previous generations, a factor which is likely to have an impact on growth rates in NRT smoking cessations aids during the forecast period and beyond.

Australia’s vaping ban under pressure from tobacco industry lobby groups

Although vaping is not technically illegal in Australia, vapour products containing nicotine are classified as poisons and are legally available only with a doctor’s prescription. However, the country’s many vapers have used a number of loopholes to access nicotine-infused vaping liquids and this has led to calls for the brand on nicotine vapour products to be lifted or amended.

COMPETITIVE LANDSCAPE

International companies continue to dominate category sales

Sales of NRT smoking cessation aids remain dominated by international companies, with local companies having almost no presence in the category. Johnson & Johnson Pacific Pty Ltd remains the outright leader with its Nicorette brand, which pulled clear of GSK Consumer Healthcare’s Nicabate over the course of the review period.

2019 sees Perrigo Australia invest in its NRT smoking cessation aids portfolio

Perrigo Australia continued to invest in its NRT smoking cessations aids portfolio in 2019, launching its new Nicotinell Combination Therapy Pack, which includes patches and gum. Nicotinell is now the only brand that offers NRT gum and NRT lozenges funded by the government’s Pharmaceutical Benefits Scheme (PBS).

Files are delivered directly into your account within a few minutes of purchase.

Samples

NRT Smoking Cessation Aids Sample Report NRT Smoking Cessation Aids Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the NRT Smoking Cessation Aids industry in Australia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the NRT Smoking Cessation Aids industry in Australia, our research will save you time and money while empowering you to make informed, profitable decisions.

The NRT Smoking Cessation Aids in Australia market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Production, imports by origin, exports by destination
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of NRT Smoking Cessation Aids in Australia?
What are the major brands in Australia?
How have tobacco bans affected the sales of NRT Smoking Cessation Aids?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

NRT Smoking Cessation Aids in Australia - Category analysis

HEADLINES

PROSPECTS

Consistently positive growth as increasing numbers of Australians quit smoking

Young Australians taken up smoking far less than previous generations

Australia’s vaping ban under pressure from tobacco industry lobby groups

COMPETITIVE LANDSCAPE

International companies continue to dominate category sales

2019 sees Perrigo Australia invest in its NRT smoking cessation aids portfolio

CATEGORY DATA

Table 1 Sales of NRT Smoking Cessation Aids by Category: Value 2014-2019
Table 2 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2015-2019
Table 4 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2016-2019
Table 5 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024
Table 6 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024

Consumer Health in Australia - Industry Overview

EXECUTIVE SUMMARY

Positive growth in consumer health as rising spending and stressful lifestyles underpin demand

Maturity in various key categories continues to suppress sales growth

Strong local companies vie with major multinational pharma players for leadership

Few changes seen as retail distribution remains stable

Positive growth to be based on population growth, rising incomes and innovation

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format and Category: % Value 2019
Table 16 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

Summary 1 OTC: Switches 2018-2019

DEFINITIONS

SOURCES

Summary 2 Research Sources

Why buy this report?

Want to find out more about this report?

Request more information

Megatrends

Country Report

NRT Smoking Cessation Aids in Australia

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Consistently positive growth as increasing numbers of Australians quit smoking

Young Australians taken up smoking far less than previous generations

Australia’s vaping ban under pressure from tobacco industry lobby groups

COMPETITIVE LANDSCAPE

International companies continue to dominate category sales

2019 sees Perrigo Australia invest in its NRT smoking cessation aids portfolio

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

NRT Smoking Cessation Aids in Australia - Category analysis

HEADLINES

PROSPECTS

Consistently positive growth as increasing numbers of Australians quit smoking

Young Australians taken up smoking far less than previous generations

Australia’s vaping ban under pressure from tobacco industry lobby groups

COMPETITIVE LANDSCAPE

International companies continue to dominate category sales

2019 sees Perrigo Australia invest in its NRT smoking cessation aids portfolio

CATEGORY DATA

Consumer Health in Australia - Industry Overview

EXECUTIVE SUMMARY

Positive growth in consumer health as rising spending and stressful lifestyles underpin demand

Maturity in various key categories continues to suppress sales growth

Strong local companies vie with major multinational pharma players for leadership

Few changes seen as retail distribution remains stable

Positive growth to be based on population growth, rising incomes and innovation

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

DEFINITIONS

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Recently Viewed

Complete Catalogue

Country Reports